Condition
NPC Patients
Total Trials
2
Recruiting
1
Active
1
Completed
0
Key Insights
Highlights
Treatment Research
2 treatments under study, led by Photon Chemoradiotherapy
Research Leaders
20 sponsors active, led by Tongji Hospital
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 2 trials
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Not Yet Recruiting1
Recruiting1
Clinical Trials (2)
Research Network
Common Treatments
- Photon Chemoradiotherapy1
- Proton Chemoradiotherapy1
Active Sponsors
- Tongji Hospital1
- Jiangsu Cancer Institute & Hospital1
- Cancer Institute and Hospital, Chinese Academy of Medical Sciences1
- Fifth Affiliated Hospital, Sun Yat-Sen University1
- Zhongnan Hospital1
Top Investigators
Department of Nasopharyngeal Carcinoma, Sun Yat-sen University Cancer Center
Chang Gung Memorial Hospital
Related Conditions
- Nasopharyngeal Cancinoma Npc1